SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a major topic of discussion following its announcement of a strategic manufacturing partnership, expected to significantly enhance production and gross margins for its fingerprint drug screening technology. This news, combined with an extremely low public float, has ignited strong, polarized opinions within the trading community, with many anticipating a substantial short squeeze. Conversely, some warn of a potential "pump and dump" given the company's prior financial hurdles, fueling the stock's high volume and extreme volatility.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp ($ESHA) is trending with intense speculative interest, driven by comparisons to other rapidly surging low-float SPACs and shell companies. The community is buzzing about its extremely tight share structure and high insider ownership, which are seen as catalysts for significant upside potential. High volatility and frequent trading halts are characteristic of the active trading, reflecting strong belief in its capacity for substantial gains.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending strongly after securing FDA approval for NEREUS, its motion-sickness treatment, which is seen as the first new pharmacologic option in decades. The community is actively discussing the drug's significant potential in addressing GLP-1 induced nausea, fueling speculation of a major pharmaceutical buyout and leading many to view the stock as currently undervalued. With additional pipeline approvals anticipated, traders are closely watching for sustained momentum as the market fully integrates this landmark development.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending amid a significant price drop, sparking a highly polarized community debate. While many express extreme bearishness, labeling it a "scam" and predicting further declines, a resilient group views current lows as a buying opportunity, citing its ISO compliance, recent network upgrades, and potential for institutional adoption. The broader crypto market sentiment continues to heavily influence discussions around XLM's future trajectory.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to a significant price drop following an FDA Complete Response Letter for its relacorilant drug for Cushing syndrome, with the agency requesting additional efficacy evidence. Community discussion is polarized, with some investors calling the sell-off an overreaction given the company's existing profitable drug Korlym and other pipeline assets. The immediate focus is on whether the company can quickly find a path forward with the FDA and if current levels present a "bargain biobuy" or a "falling knife."

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending amid high anticipation for a time-sensitive Department of Energy announcement on surplus plutonium allocation, a key catalyst for its advanced nuclear technology. Bulls are interpreting current price stability and dark pool activity as institutional positioning before potential upside, linking Oklo to the escalating energy demands of AI. Meanwhile, bears remain vocal about the company's zero revenue, high market capitalization, and recent insider share sales, fueling debate over its valuation.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending following the FDA's decline to approve a competitor's Cushing's syndrome treatment, which gives Recorlev a clearer path to capture significant market share. The community is buzzing with bullish sentiment, anticipating robust growth and discussing how this immediate catalyst, alongside the company's improving profitability, should drive a substantial re-rating of the stock.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the extension of China's NEV trade-in subsidies into 2026 fuels optimism across the sector, coinciding with an upbeat Q4 sales forecast from management suggesting potential profitability. While bulls are aggressively buying recent dips and anticipating a strong year-end, skeptics remain wary of past volatility and alleged market manipulation.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is surging due to recent FDA updates, including priority review acceptance for AXS-05 for Alzheimer's disease agitation and positive pre-NDA meeting minutes supporting an AXS-12 submission for narcolepsy. The community is celebrating these significant advancements, seeing them as key catalysts driving the company toward profitability and anticipating further growth in its CNS portfolio.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

2 ETFs to Watch for Outsized Volume on Emerging Market Stocks

EEMA and EDZ saw trading volumes soar to more than double their averages, signaling rising investor focus on emerging market ETFs.  

The Likely Winners of a U.S.-China Trade Thaw: Asia Pacific Emerging ETFs

As Trump and Xi are expected to meet at the APEC Summit, optimism grows for Asia-Pacific Emerging ETFs poised to gain from a U.S.-China trade thaw.   


Southeast Asian manufacturers' optimism about future growth has slumped to their lowest levels since the COVID-19 pandemic despite a rebound in activity amid the onset of U.S. President Donald Trump’s tariffs.According to the S&amp;P Global ASEAN Manufacturing Purchasing Manager’s Index report, confidence for the year-ahead output slumped to the lowest level in five years, with producers expecting relatively tepid growth over the next 12 months compared to the historical average.The weak sentiment stood in sharp contrast to the July manufacturing activity in the region, which rose to 50.1 from 48.6 in June. A figure higher than 50 implies an expansion of activities. The report added that new orders declined only marginally, marking the softest decrease in the current four-month sequence of contraction, which hints at a possible rebound in demand.Retail sentiment on Stocktwits about the <a href="https://stocktwits.com/symbol/EEMA">iShares MSCI Emerging Markets</a> Asia ETF (EEMA) was in the ‘neutral’ territory at the time of writing.Factories in the heavily trade-reliant economies of Southeast Asia have been upended by uncertainty around Trump’s tariffs. However, in July, most countries in the region were able to strike trade deals with the U.S., with varying rates of tariffs ranging from 10% to 40%.The survey also found that buying activity remained stable in July compared to the previous month, while staffing reductions were implemented at a slower pace. However, despite the positives, manufacturers were not very bullish about the future.“Optimism reached its lowest point in five years, well below the long-run average. While an increase in output is anticipated, the growth rate is expected to remain subdued,” said S&amp;P Global economist Maryam Baluch.On Thursday, official data showed that China’s factory activity in July slumped to its lowest level since April, despite the easing of U.S. tariffs, amid signs of weakness in exports and tepid domestic consumption.The iShares MSCI Emerging Markets Asia ETF has risen 16.7% this year, while the SPDR S&amp;P 500 ETF Trust (SPY), which tracks the S&amp;P 500 index, has gained 7.2%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/trump-reportedly-taps-wall-street-banks-to-explore-fannie-freddie-public-offering-strategy/chr3jywRdGL">Trump Reportedly Taps Wall Street Banks To Explore Fannie, Freddie Public Offering Strategy — Retail Eyes Fresh Highs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Female workers at a Thai Son S.P. Co. garment factory endeavor to produce products for global clients, in Thu Duc, Ho Chi Minh, Vietnam, on June 21, 2025.

With Trump Tariffs Kicking In, Southeast Asia’s Factory Mood Slips To Pandemic-Era Lows

According to the S&P Global ASEAN Manufacturing Purchasing Manager’s Index report, confidence for the year-ahead output slumped to the lowest level in five years.

Equity

U.S. Commerce Secretary Howard Lutnick said on Wednesday that the Trump administration has struck trade deals with Thailand and Cambodia, days after the countries agreed to a truce following deadly clashes due to a border dispute.In an interview with Fox News’s Sean Hannity, Lutnick said, “And you know what we did today? We made trade deals with Cambodia and Thailand.” However, he did not divulge any details before the interview ended.Both Thailand and Cambodia were slated to face a tariff rate of 36% from Friday, which would have dealt a blow to the trade-reliant countries as the U.S. is their largest destination for exported goods. Neighbors Indonesia and the Philippines have already secured lower rates of 19%, while Vietnam has agreed to 20% tariffs on its goods.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/THD">iShares MSCI Thailand ETF</a> (THD) was in the ‘neutral’ territory at the time of writing. At the same time, traders were ‘bullish’ about iShares MSCI Emerging Markets Asia ETF (EEMA).U.S. President Donald Trump has thus far utilized trade as a potent tool to mitigate global conflicts. He had threatened to pull out of trade discussions with both countries unless they agreed to a ceasefire after fatal clashes claimed the lives of dozens.According to a Bloomberg News <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-07-31/us-made-trade-deals-with-thailand-cambodia-lutnick-says">report</a>, Sun Chanthol, the Cambodian Deputy Prime Minister leading the trade talks, stated that he was unaware of any new agreement. Thailand reportedly expects the final levy to be between 18% and 20%, similar to its regional neighbors.The U.S. goods trade deficit with Thailand reached $45.6 billion in 2024, and $12.1 billion with Cambodia, which has a smaller economy than its neighbor. Thailand and Cambodia have already offered concessions to sweeten the tariff blow.Other countries are also rushing to ink a deal with the U.S. ahead of the Aug. 1 deadline. South Korea agreed to a 15% tariff rate, while the White House levied 25% tariffs on India and threatened a penalty for the country’s oil imports from Russia.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/china-factory-activity-slips-despite-trade-us-truce-is-the-dragon-losing-its-fire/chohDrgR5Cv">China Factory Activity Slips Despite Trade US Truce — Is The Dragon Losing Its Fire?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Howard Lutnick listens as U.S. President Donald Trump delivers remarks before Lutnick is sworn in as Commerce Secretary in the Oval Office at the White House on February 21, 2025.

Lutnick Says US Struck Trade Deals With Thailand, Cambodia Following Ceasefire — But Details Unclear

Both Southeast Asian countries were slated to face a tariff rate of 36% from Friday.

EEMA
iShares MSCI Emerging Markets Asia ETF

Feed

News

Sentiment

Fundamentals

Info

Latest EEMA News

EEMAiShares MSCI Emerging Markets Asia ETF